Searched for
RAMPRASAD CHAIRMAN
Genomics diagnostics firm MedGenome rejigs top leadershipMahesh Pratapneni, who co‐founded MedGenome with Santhosh, will take over as Group CEO. Dr. Felix Olale, Partner of LeapFrog Investments, w...- MedGenome Labs brings on board new CEOCurrently, genomics is widely used in areas such as oncology, infectious diseases (especially tuberculosis), rare diseases, reproductive he...
- How clerk-turned-billionaire Ramprasad Reddy made Aurobindo a giant pharma companyRamprasad Reddy has his skin the game; he has made some timely bets with a nifty strategy for Aurobindo.
- Manage your plastic waste responsibly: KSPCB to companiesKSPCB has decided to get cracking on the Plastic Waste Management Rules, 2016, which includes imposing EPR on manufacturers, sellers and im...
- Defending champion Stuart Oliver upset over Tata Motors' truck racing championship exclusionOliver says the exclusion is most likely because of the fall out with Steve Horne, founder of Steve Horne Truck Racing.
- MAPE Advisory Group to invest Rs 30 crore in NetMeds MarketplaceMAPE Advisory along with founder Pradeep Dadha are initially pumping in Rs 30 crore in the firm, with a commitment to increase it to Rs 60 ...
- Gautam Adani breaks into India's top 10 rich club as wealth jumps 152%Adani blazed into the top league riding on the runaway share prices of his companies in recent past.
- Rangarajan panel report on oil, gas pricing in 2nd half of DecemberThe Prime Minister-appointed Rangarajan Committee is likely to present its report on changes in the regime governing oil and gas exploratio...
- Rangarajan panel report on oil, gas pricing in December first weekRangarajan Committee is likely to present in the first week of December its report on changes in the present regime governing oil and gas e...
- Aurobindo Pharma reports Q3 net loss of Rs 28.54 crAurobindo Pharma posted a consolidated net loss of Rs 28.54 crore for Q3, primarily on account of foreign exchange losses suffered during t...
- Aurobindo Pharma posts Rs 80.16 cr loss in Q2Aurobindo Pharma today posted a consolidated net loss of Rs 80.16 crore for the second quarter ended September 30, 2011.
- Aurobindo Pharma posts net loss of Rs 122.80 cr in Q1The company had reported a net profit of Rs 51.50 crore for the same period previous fiscal, Aurobindo Pharma said in a statement.
- Investment banks emerging as a force to reckon withBoutique bankers are making hay as many medium and small-sized cos are up for grabs with even among well-established players in i-banking.
- Aurobindo Pharma FY'11 net up marginally at Rs 563.45 crDrug firm Aurobindo Pharma today said its consolidated net profit rose marginally to Rs 563.45 crore for the year ended March 31, 2011.
- Aurobindo Pharma Q3 net up 9.81 pc to Rs 188.63 crDrug firm Aurobindo Pharma today said its consolidated net profit rose by 9.81 per cent to Rs 188.63 crore for the third quarter ended Dece...
- Aurobindo Pharma signs supply pact with AstraZenecaAurobindo Pharma said it has entered into an agreement with AstraZeneca to supply solid dosage & sterile products to emerging markets.
- Aurobindo Q1 net dips 69 pc to Rs 51 crDrug maker Aurobindo Pharma said its consolidated net profit declined 69.08 per cent to Rs 51.50 crore for the first quarter ended June 30,...
- Aurobindo hopes to become $2 bn company in 3 yrsAurobindo Pharma hopes to become a $2-billion company in the next three years, aided by improved sales from its API business and increase i...
- Tax hike hits foreign garment brandsGarment retailers such as Marks & Spencer, Wills Lifestyle and Orient Craft are having a rather gloomy festival season, despite consumers f...
- Five Indians among most influential in global pharma industryList also includes Bill Clinton, founder of Clinton Foundation, at the 9th position and Warren Buffet ranked at 25th.India Inc's hotshots I...
Load More
